Irina E Penev, PA-C
Physician Assistant · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Irina E Penev’s office at (650) 723-4000 to ask if they take your plan before you enroll.
California Medical Board record
Licence G60115 · Current
Licensed to practise in California · since 1987 · expires 2027-03-31 · State University of New York, Downstate Medical Center College of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Washington PA.PA.60162546Physician Assistant License · since 2010 · expires 2027-03-05ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Drugs they prescribed that Part D paid
$31,648
Pharmacies billed $31,648 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
261 generic and fewer than 11 brand-name prescriptions · $31,648 in drug cost · 13 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atovaquone | 14 | $8,730 | $624 |
| Sirolimus | 11 | $798 | $73 |
| Pantoprazole | 17 | $254 | $15 |
| Pregabalin | 15 | $137 | $9 |
| Amlodipine Besylate | 13 | $95 | $7 |
See all 6 drugs
| Atovaquone | 14 | $8,730 | $624 |
| Sirolimus | 11 | $798 | $73 |
| Pantoprazole | 17 | $254 | $15 |
| Pregabalin | 15 | $137 | $9 |
| Amlodipine Besylate | 13 | $95 | $7 |
| Metoprolol | 12 | $88 | $7 |
Year by year
| 2024 | 291 | 35 | None | None | $31,648 |
| 2023 | 123 | 29 | None | 9% | $24,642 |
| 2022 | 154 | 34 | None | None | $17,003 |
| 2021 | 111 | 81 | 0% (0) | None | $2,019 |
| 2020 | 51 | 48 | 0% (0) | None | $358 |
| 2019 | 66 | 53 | 0% (0) | None | $575 |
| 2018 | 17 | 14 | 0% (0) | None | $211 |
| 2017 | 34 | 23 | 0% (0) | None | $879 |
| 2016 | 164 | 67 | 0% (0) | 11% | $1,925 |
| 2015 | 1,174 | 180 | 0% (0) | 21% | $31,814 |
| 2014 | 1,419 | 241 | 0% (0) | 17% | $32,395 |
| 2013 | 1,065 | 195 | None | 15% | $31,586 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Atovaquone | 11 | $7,692 | $699 |
2022: 2 drugs
| Eliquis | 13 | $7,349 | $565 |
| Metoprolol | 13 | $167 | $13 |
2021: 3 drugs
| Mupirocin | 66 | $587 | $9 |
| Enoxaparin | 12 | $380 | $32 |
| Prednisone | 11 | $21 | $2 |
2020: 2 drugs
| Mupirocin | 33 | $258 | $8 |
| Prednisone | 13 | $19 | $1 |
2019: 3 drugs
| Enoxaparin | 11 | $247 | $22 |
| Mupirocin | 28 | $234 | $8 |
| Prednisone | 13 | $20 | $2 |
2016: 3 drugs
| Atorvastatin | 24 | $301 | $13 |
| Amlodipine Besylate | 12 | $112 | $9 |
| Carvedilol | 12 | $84 | $7 |
2015: 23 drugs
| Effient | 33 | $12,901 | $391 |
| Vytorin | 11 | $2,490 | $226 |
| Metoprolol | 95 | $2,217 | $23 |
| Clopidogrel | 101 | $1,584 | $16 |
| Atorvastatin | 122 | $1,383 | $11 |
| Potassium Chloride | 44 | $1,245 | $28 |
| Carvedilol | 97 | $710 | $7 |
| Eplerenone | 11 | $625 | $57 |
| Hydralazine | 39 | $592 | $15 |
| Amlodipine Besylate | 81 | $581 | $7 |
| Isosorbide Mononitrate Er | 34 | $503 | $15 |
| Furosemide | 118 | $493 | $4 |
| Digoxin | 18 | $352 | $20 |
| Lisinopril | 62 | $326 | $5 |
| Nitrostat | 18 | $257 | $14 |
| Amiodarone | 18 | $205 | $11 |
| Spironolactone | 44 | $188 | $4 |
| Losartan | 32 | $166 | $5 |
| Metoprolol | 37 | $123 | $3 |
| Clonidine | 17 | $89 | $5 |
| Simvastatin | 15 | $76 | $5 |
| Pantoprazole | 12 | $54 | $5 |
| Hydrochlorothiazide | 17 | $38 | $2 |
2014: 25 drugs
| Effient | 31 | $8,243 | $266 |
| Metoprolol | 137 | $4,931 | $36 |
| Clopidogrel | 132 | $2,194 | $17 |
| Atorvastatin | 138 | $1,905 | $14 |
| Potassium Chloride | 36 | $846 | $24 |
| Hydralazine | 56 | $745 | $13 |
| Amlodipine Besylate | 105 | $722 | $7 |
| Digoxin | 13 | $644 | $50 |
| Furosemide | 150 | $638 | $4 |
| Lisinopril | 85 | $523 | $6 |
| Digox | 21 | $491 | $23 |
| Carvedilol | 52 | $476 | $9 |
| Nitrostat | 30 | $425 | $14 |
| Losartan | 56 | $375 | $7 |
| Isosorbide Mononitrate Er | 28 | $366 | $13 |
| Metoprolol | 67 | $349 | $5 |
| Amiodarone | 13 | $238 | $18 |
| Metolazone | 24 | $175 | $7 |
| Spironolactone | 34 | $159 | $5 |
| Klor-Con M20 | 12 | $125 | $10 |
| Pantoprazole | 22 | $106 | $5 |
| Atenolol | 15 | $99 | $7 |
| Warfarin | 14 | $94 | $7 |
| Simvastatin | 13 | $88 | $7 |
| Hydrochlorothiazide | 25 | $59 | $2 |
2013: 22 drugs
| Diovan | 23 | $3,614 | $157 |
| Metoprolol | 54 | $2,933 | $54 |
| Atorvastatin | 75 | $1,545 | $21 |
| Clopidogrel | 50 | $1,524 | $30 |
| Furosemide | 126 | $724 | $6 |
| Isosorbide Mononitrate Er | 46 | $656 | $14 |
| Carvedilol | 56 | $597 | $11 |
| Amlodipine Besylate | 78 | $566 | $7 |
| Spironolactone | 72 | $539 | $7 |
| Lisinopril | 55 | $508 | $9 |
| Potassium Chloride | 28 | $463 | $17 |
| Klor-Con M20 | 21 | $354 | $17 |
| Amiodarone | 15 | $331 | $22 |
| Pantoprazole | 22 | $323 | $15 |
| Warfarin | 15 | $294 | $20 |
| Losartan | 25 | $284 | $11 |
| Nitrostat | 23 | $259 | $11 |
| Metolazone | 28 | $241 | $9 |
| Metoprolol | 61 | $234 | $4 |
| Hydralazine | 14 | $162 | $12 |
| Simvastatin | 15 | $141 | $9 |
| Hydrochlorothiazide | 33 | $87 | $3 |
Money from drug and device companies
$5,400 in 2021
A payment is not proof that care is biased.
| Edwards Lifesciences | None | $5,400 | 4 payments
|
See all 4 published payments
| Edwards Lifesciences | Consulting · 2021-10-04 | None | $1,200 |
| Edwards Lifesciences | Consulting · 2021-10-04 | None | $975 |
| Edwards Lifesciences | Consulting · 2021-02-18 | None | $1,350 |
| Edwards Lifesciences | Consulting · 2021-01-07 | None | $1,875 |
Professional record
- NPI
- 1851361646
- Licence
- CA 60115, WA PA60162546California G60115: Current · expires 2027-03-31Washington PA.PA.60162546: Active
More record details
- Sole proprietor
- No
- Medicaid ID
- WA 1851361646
- Taxonomy
- Physician assistant (363A00000X); Physician assistant, surgical (363AS0400X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-01-24
- NPI last updated
- 2022-02-03
- NPI record certified
- 2022-02-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1550 N 115th St, Seattle, WA, 98133 · 550 17th Ave Fl 6, Seattle, WA, 98122